drugset / Press release
Cytophage CEO to Discuss Reshaping Healthcare Through Phage Therapies During 2024 Canada SynBio Conference
2024-10-04 · Cytophage Technologies Inc. · original cytophage.com ↗
Winnipeg, October 4, 2024. Cytophage Technologies (TSXV:CYTO) (“Cytophage” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both animal health and human health, today announced that its CEO, Dr. Steven Theriault, has been invited to participate in this year’s Canada SynBio Conference.
The release as fetched from its publisher. cytophage.com ↗